An integrated 2H and 13C NMR study of gluconeogenesis and TCA cycle flux in humans

被引:111
作者
Jones, JG
Solomon, MA
Cole, SM
Sherry, AD
Malloy, CR
机构
[1] Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75235 USA
[2] Dept Vet Affairs Med Ctr, Dallas, TX 75216 USA
[3] Univ Dallas, Dept Chem, Richardson, TX 75083 USA
[4] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75216 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2001年 / 281卷 / 04期
关键词
monoacetone glucose; acetaminophen glucuronide; carbon; 13; deuterium; gluconeogenesis; liver metabolism;
D O I
10.1152/ajpendo.2001.281.4.E848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatic glucose synthesis from glycogen, glycerol, and the tricarboxylic acid (TCA) cycle was measured in five overnight-fasted subjects by H-1, H-2, and C-13 NMR analysis of blood glucose, urinary acetaminophen glucuronide, and urinary phenylacetylglutamine after administration of [1,6-C-13(2)]glucose, (H2O)-H-2, and [U-C-13(3)]propionate. This combination of tracers allows three separate elements of hepatic glucose production (GP) to be probed simultaneously in a single study: 1) endogenous GP, 2) the contribution of glycogen, phosphoenolpyruvate (PEP), and glycerol to GP, and 3) flux through PEP carboxykinase, pyruvate recycling, and the TCA cycle. Isotope-dilution measurements of [1,6-C-13(2)] glucose by H-1 and C-13 NMR indicated that GP in 16-h-fasted humans was 10.7 +/- 0.9 mu mol.kg(-1).min(-1). H-2 NMR spectra of monoacetone glucose (derived from plasma glucose) provided the relative 2H enrichment at glucose H-2, H-5, and H-6S, which, in turn, reflects the contribution of glycogen, PEP, and glycerol to total GP (5.5 +/- 0.7, 4.8 +/- 1.0, and 0.4 +/- 0.3 mu mol.kg(-1).min(-1), respectively). Interestingly, C-13 NMR isotopomer analysis of phenylacetylglutamine and acetaminophen glucuronide reported different values for PEP carboxykinase flux (68.8 +/- 9.8 vs. 37.5 +/- 7.9 mu mol.kg(-1).min(-1)), PEP recycling flux (59.1 +/- 9.8 vs. 27.8 +/- 6.8 mu mol.kg(-l).min(-1)), and TCA cycle flux (10.9 +/- 1.4 vs. 5.4 +/- 1.4 mu mol.kg(-1).min(-1)). These differences may reflect zonation of propionate metabolism in the liver.
引用
收藏
页码:E848 / E856
页数:9
相关论文
共 47 条
  • [1] BABA H, 1995, NUTRITION, V11, P149
  • [2] Beylot M, 1997, DIABETES METAB, V23, P251
  • [3] New methods for in vivo studies of hepatic metabolism
    Beylot, M
    Peroni, O
    Diraison, F
    Large, V
    [J]. REPRODUCTION NUTRITION DEVELOPMENT, 1996, 36 (04): : 363 - 373
  • [4] Quantification of gluconeogenesis in cirrhosis: Response to glucagon
    Bugianesi, E
    Kalhan, S
    Burkett, E
    Marchesini, G
    McCullough, A
    [J]. GASTROENTEROLOGY, 1998, 115 (06) : 1530 - 1540
  • [5] Burgarella F, 2000, PERFUSION, V13, P41
  • [6] Quantifying gluconeogenesis during fasting
    Chandramouli, V
    Ekberg, K
    Schumann, WC
    Kalhan, SC
    Wahren, J
    Landau, BR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06): : E1209 - E1215
  • [7] Origins of the hydrogen bound to carbon 1 of glucose in fasting: significance in gluconeogenesis quantitation
    Chandramouli, V
    Ekberg, K
    Schumann, WC
    Wahren, J
    Landau, BR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (04): : E717 - E723
  • [8] The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects
    Chen, XH
    Iqbal, N
    Boden, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) : 365 - 372
  • [9] Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM
    Diraison, F
    Large, V
    Brunengraber, H
    Beylot, M
    [J]. DIABETOLOGIA, 1998, 41 (02) : 212 - 220
  • [10] Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine
    Diraison, F
    Large, V
    Maugeais, C
    Krempf, M
    Beylot, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03): : E529 - E536